Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Penile cancer: an overview.

R Hamid1, I Shergill, M Arya

  • 1Institute of Urology, London W1W 7EY.

Hospital Medicine (London, England : 1998)
|January 7, 2003
PubMed
Summary

Penile carcinoma is rare, affecting 1 in 100,000 men annually. Early diagnosis improves survival, but delayed presentation and metastatic disease treatment remain challenging for this rare cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accelerated MRI-Guided Brachytherapy in Cervical Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Psychological Burden of Rheumatoid Arthritis in Bangladesh: The Influence of Pain Catastrophizing and Depression.

Mymensingh medical journal : MMJ·2026
Same author

Eyes Are the Window of the Brain: Neuro-Ophthalmic Correlations.

Mymensingh medical journal : MMJ·2025
Same author

AWARENESS, USE AND EFFECTIVENESS OF EMERGENCY CONTRACEPTION.

Georgian medical news·2025
Same author

Role of Ommaya Reservoir in Pediatric Hydrocephalus: Experience in Bangladesh Medical College Hospital from 2019-2021.

Mymensingh medical journal : MMJ·2023
Same author

Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine.

Archives of Razi Institute·2022

Area of Science:

  • Oncology
  • Urology

Background:

  • Penile carcinoma is a rare malignancy in developed countries, representing less than 1% of adult cancers.
  • The incidence rate is approximately 1 in 100,000 men per year globally.

Purpose of the Study:

  • To highlight the incidence and survival rates of penile carcinoma.
  • To emphasize the importance of early diagnosis in improving patient outcomes.
  • To address the challenges in treating advanced or metastatic penile cancer.

Main Methods:

  • This study is a review of existing literature on penile carcinoma.
  • Data on incidence, diagnosis, and treatment outcomes were analyzed.

Main Results:

  • Survival rates for penile carcinoma are significantly higher when diagnosed at early stages.
  • A considerable delay, often up to a year, occurs between lesion appearance and medical presentation for most patients.
  • Current treatment options for metastatic penile carcinoma yield disappointing results.

Conclusions:

  • Early detection is crucial for improving survival in penile carcinoma patients.
  • Delayed diagnosis and the lack of effective treatments for metastatic disease are significant clinical challenges.
  • Further research is needed to develop more effective therapeutic strategies for advanced penile cancer.

Related Experiment Videos